| Literature DB >> 24309090 |
Abstract
INTRODUCTION: Little is known about the relationship between food security status and predicted 10-year cardiovascular disease risk. The objective of this study was to examine the associations between food security status and cardiovascular disease risk factors and predicted 10-year risk in a national sample of US adults.Entities:
Mesh:
Year: 2013 PMID: 24309090 PMCID: PMC3854876 DOI: 10.5888/pcd10.130244
Source DB: PubMed Journal: Prev Chronic Dis ISSN: 1545-1151 Impact factor: 2.830
Least-Square Adjusted Means of Risk Factors for Cardiovascular Disease Among Participants (N = 10,455) Aged 20 Years or Older, by Food Security Status, National Health and Nutrition Examination Surveys, 2003–2008
| Risk Factor | Food Security Status |
| |||
|---|---|---|---|---|---|
| Full (n = 8,145) | Marginal (n = 976) | Low (n = 857) | Very Low (n = 477) | ||
| Model 1 | |||||
| HbA1c | 5.45 (0.01) | 5.50 (0.04) | 5.54 (0.03) | 5.64 (0.08) | .006 |
| Systolic blood pressure, mm Hg | 121.3 (0.3) | 121.5 (0.7) | 120.5 (0.8) | 122.9 (0.8) | .18 |
| Total cholesterol, mg/dL | 199.5 (0.6) | 201.5 (1.6) | 200.4 (1.7) | 202.1 (2.6) | .61 |
| High-density lipoprotein cholesterol, mg/dL | 53.8 (0.2) | 51.9 (0.6) | 52.7 (0.8) | 52.4 (0.9) | <.001 |
| Non-high-density lipoprotein cholesterol, mg/dL | 145.7 (0.6) | 149.7 (1.5) | 147.7 (2.0) | 149.7 (2.6) | .06 |
| Body mass index, kg/m2 | 28.2 (0.1) | 29.0 (0.3) | 28.6 (0.3) | 29.0 (0.6) | .01 |
| Cotinine, ng/mL | 61.9 (2.1) | 84.1 (6.0) | 89.7 (7.7) | 113.4 (9.4) | <.001 |
| C-reactive protein, mg/L | 3.9 (0.1) | 4.0 (0.2) | 3.8 (0.2) | 5.1 (0.5) | .02 |
| Urinary albumin–creatinine ratio, mg/g | 22.3 (1.9) | 25.9 (4.4) | 30.1 (7.8) | 33.8 (10.2) | .57 |
|
| |||||
| HbA1c | 5.45 (0.01) | 5.47 (0.03) | 5.53 (0.03) | 5.61 (0.08) | .04 |
| Systolic blood pressure, mm Hg | 121.3 (0.3) | 121.2 (0.7) | 120.4 (0.7) | 122.6 (0.8) | .32 |
| Total cholesterol, mg/dL | 199.6 (0.6) | 201.4 (1.6) | 200.2 (1.7) | 200.8 (2.6) | .73 |
| High-density lipoprotein cholesterol, mg/dL | 53.7 (0.2) | 52.5 (0.5) | 53.2 (0.8) | 53.5 (0.8) | .06 |
| Non-high-density lipoprotein cholesterol, mg/dL | 146.0 (0.6) | 148.5 (1.5) | 146.8 (2.0) | 147.2 (2.6) | .43 |
| Body mass index, kg/m2 | 28.2 (0.1) | 28.7 (0.2) | 28.6 (0.3) | 28.6 (0.5) | .10 |
| Cotinine, ng/mL | 62.0 (2.2) | 83.8 (6.1) | 89.3 (7.6) | 112.8 (9.0) | <.001 |
| C-reactive protein, mg/L | 3.9 (0.1) | 3.8 (0.2) | 3.6 (0.2) | 4.8 (0.4) | .04 |
| Urinary albumin-creatinine ratio, mg/g | 22.7 (2.0) | 25.0 (4.4) | 29.3 (7.3) | 27.3 (10.3) | .81 |
Abbreviation: HbA1c, hemoglobin A1c.
Values are mean (standard error), unless otherwise indicated.
Calculated by using adjusted Wald F test.
Model 1 is adjusted for age, sex, race/ethnicity, educational status, health insurance coverage, and alcohol use.
Model 2 is adjusted for variables in Model 1 plus other cardiovascular disease risk factors shown in this table.
Age-Adjusted Prevalence (% [SE]) of Abnormal Risk Factors for Cardiovascular Disease and Adjusted Prevalence Ratios (95% CI) for Abnormal Risk Factors for Cardiovascular Disease Among Participants (N = 10,455) Aged 20 years or Older, National Health and Nutrition Examination Surveys, 2003–2008
| Risk Factor | Food Security Status |
| |||
|---|---|---|---|---|---|
| Full (n = 8,145) | Marginal (n = 976) | Low (n = 857) | Very low (n = 477) | ||
| Prevalence | |||||
| HbA1c ≥6.5% or use of insulin or hypoglycemic oral medications | 7.1 (0.4) | 11.5 (1.5) | 10.6 (1.3) | 14.6 (2.4) | <.001 |
| Hypertension | 28.4 (0.6) | 31.8 (2.2) | 27.9 (2.1) | 36.8 (3.0) | .001 |
| Current smoker | 21.5 (0.8) | 32.7 (1.8) | 32.9 (2.0) | 45.9 (3.2) | <.001 |
| Cotinine >10 ng/mL | 25.7 (1.0) | 35.0 (2.1) | 35.1 (1.9) | 50.1 (3.2) | <.001 |
| Total cholesterol ≥200 mg/dL or use of cholesterol-lowering medications | 53.9 (0.7) | 55.1 (2.0) | 52.0 (1.9) | 54.7 (2.5) | .96 |
| Low high-density lipoprotein cholesterol | 27.2 (0.8) | 34.2 (1.8) | 31.9 (2.0) | 34.8 (2.3) | <.001 |
| Non-high-density lipoprotein cholesterol ≥130 mg/dL | 62.3 (0.7) | 65.9 (2.1) | 60.9 (2.3) | 62.4 (2.7) | .65 |
| Body mass index ≥30 kg/m2 | 31.2 (0.8) | 38.2 (1.7) | 36.1 (2.0) | 36.3 (3.0) | .001 |
| C-reactive protein >3 mg/L | 31.5 (0.7) | 40.9 (1.7) | 34.9 (2.0) | 42.4 (3.5) | <.001 |
| Urinary albumin–creatinine ratio ≥30 mg/g | 8.0 (0.3) | 10.9 (1.4) | 14.1 (1.5) | 11.7 (2.0) | <.001 |
|
| |||||
|
| |||||
| HbA1c ≥6.5% or use of insulin or hypoglycemic oral medications | 1 [Reference] | 1.18 (0.90–1.54) | 1.09 (0.83–1.43) | 1.84 (1.26–2.69) | .01 |
| Hypertension | 1.08 (0.94–1.25) | 0.92 (0.77–1.11) | 1.38 (1.11–1.71) | .004 | |
| Current smoker | 1.36 (1.20–1.54) | 1.38 (1.23–1.54) | 1.66 (1.46–1.88) | <.001 | |
| Cotinine >10 ng/mL | 1.28 (1.13–1.45) | 1.27 (1.15–1.40) | 1.54 (1.37–1.72) | <.001 | |
| Total cholesterol ≥200 mg/dL or use of cholesterol-lowering medications | 1.03 (0.93–1.13) | 1.02 (0.93–1.11) | 1.05 (0.94–1.17) | .76 | |
| Low high-density lipoprotein cholesterol | 1.04 (0.97–1.11) | 1.00 (0.93–1.07) | 1.00 (0.90–1.10) | .002 | |
| Non-high-density lipoprotein cholesterol ≥130 mg/dL | 1.18 (1.06–1.32) | 1.10 (0.97–1.26) | 1.20 (1.02–1.41) | .73 | |
| Body mass index ≥30 kg/m2 | 1.15 (1.03–1.28) | 1.10 (0.98–1.23) | 1.14 (0.96–1.35) | .03 | |
| C-reactive protein >3 mg/L | 1.17 (1.06–1.28) | 1.07 (0.95–1.21) | 1.25 (1.03–1.51) | .002 | |
| Urinary albumin-creatinine ratio ≥30 mg/g | 1.27 (0.96–1.67) | 1.41 (1.13–1.75) | 1.49 (1.01–2.20) | .01 | |
|
| |||||
| HbA1c ≥6.5% or use of insulin or hypoglycemic oral medications | 1 [Reference] | 1.11 (0.85–1.44) | 1.02 (0.78–1.34) | 1.37 (0.89–2.10) | .48 |
| Hypertension | 1.04 (0.90–1.19) | 0.88 (0.75–1.04) | 1.21 (0.98–1.50) | .08 | |
| Current smoker | 1.33 (1.17–1.50) | 1.36 (1.22–1.51) | 1.61 (1.43–1.82) | <.001 | |
| Cotinine >10 ng/mL | 1.25 (1.10–1.42) | 1.25 (1.14–1.37) | 1.50 (1.34–1.68) | <.001 | |
| Total cholesterol ≥200 mg/dL or use of cholesterol-lowering medications | 1.01 (0.92–1.12) | 1.00 (0.92–1.09) | 1.01 (0.91–1.13) | .99 | |
| Low high-density lipoprotein cholesterol | 1.12 (1.01–1.24) | 1.05 (0.92–1.20) | 0.99 (0.80–1.23) | .18 | |
| Non-high-density lipoprotein cholesterol ≥130 mg/dL | 1.02 (0.96–1.08) | 0.98 (0.91–1.06) | 0.96 (0.87–1.05) | .73 | |
| Body mass index ≥30 kg/m2 | 1.11 (1.00–1.22) | 1.08 (0.96–1.21) | 1.04 (0.89–1.22) | .17 | |
| C-reactive protein >3 mg/L | 1.06 (0.9–1.17) | 0.98 (0.87–1.10) | 0.98 (0.82–1.18) | .25 | |
| Urinary albumin–creatinine ratio ≥30 mg/g | 1.26 (0.97–1.63) | 1.32 (1.06–1.65) | 1.24 (0.86–1.79) | .04 | |
Abbreviations: SE, standard error; CI, confidence interval; HbA1c, hemoglobin A1c.
Calculated by using Wald χ2 test.
Adjusted for age, sex, race/ethnicity, educational status, health insurance coverage, and alcohol use.
Adjusted for variables in Model 1 plus HbA1c, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, body mass index, cotinine, C-reactive protein, and urinary albumin–creatinine ratio.
Least-Square Adjusted Means (SE) for Body Mass Index and Adjusted Prevalence Ratios (95% CI) Among Participants (N = 10,455) Aged 20 Years or Older, by Sex and Food-Security Status, National Health and Nutrition Examination Surveys, 2003–2008
| Variable | Food Security Status |
| |||
|---|---|---|---|---|---|
| Full | Marginal | Low | Very low | ||
|
| |||||
|
| |||||
| Model 1 | 28.4 (0.1) | 28.4 (0.4) | 27.9 (0.4) | 28.2 (0.6) | .59 |
| Model 2 | 28.4 (0.1) | 28.2 (0.3) | 28.0 (0.3) | 28.1 (0.6) | .62 |
|
| |||||
| Model 1 | 28.0 (0.2) | 29.4 (0.3) | 29.2 (0.4) | 29.7 (0.7) | <.001 |
| Model 2 | 28.0 (0.1) | 29.2 (0.3) | 29.1 (0.4) | 29.1 (0.5) | <.001 |
|
| |||||
|
| |||||
| Model 1 | 1 [Reference] | 1.01 (0.84–1.22) | 0.86 (0.71–1.04) | 0.89 (0.71–1.13) | .39 |
| Model 2 | 1 [Reference] | 0.97 (0.82–1.15) | 0.88 (0.74–1.05) | 0.88 (0.71–1.08) | .37 |
|
| |||||
| Model 1 | 1 [Reference] | 1.26 (1.10–1.43) | 1.29 (1.13–1.47) | 1.33 (1.07–1.66) | <.001 |
| Model 2 | 1 [Reference] | 1.23 (1.08–1.40) | 1.26 (1.09–1.47) | 1.17 (0.97–1.42) | <.001 |
Abbreviations: SE, standard error; CI, confidence interval; HbA1c, hemoglobin A1c.
Calculated by using adjusted Wald F test or Wald χ2 test.
Adjusted for age, race/ethnicity, educational status, health insurance coverage, and alcohol use.
Adjusted for variables in Model 1 plus HbA1c, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, cotinine, C-reactive protein, and urinary albumin–creatinine ratio.
Defined as body mass index ≥30 kg/m2.
FigureLeast-square adjusted mean (95% confidence interval) predicted 10-year cardiovascular disease risk (Panel A) and adjusted prevalence ratios (95% confidence interval) for predicted 10-year cardiovascular disease risk greater than 20% (Panel B) among adults aged 30 to 74 years, by age group and food security status, National Health and Nutrition Examination Survey 2003–2008. Results are adjusted for sex, race/ethnicity, educational status, health insurance status, alcohol use, body mass index, and concentration of C-reactive protein.
|
| |||
|
|
|
|
|
|
|
| 6.5 | 6.2–6.9 |
|
| 6.2 | 5.1–7.3 | |
|
| 5.7 | 4.8–6.5 | |
|
| 8.0 | 6.5–9.6 | |
|
|
| 19.1 | 18.2–20.1 |
|
| 19.9 | 16.1–23.7 | |
|
| 18.3 | 15.0–21.5 | |
|
| 20.9 | 16.6–25.2 | |
|
| |||
|
|
|
|
|
|
|
| 1 [Reference] | |
|
| 0.92 | 0.48–1.77 | |
|
| 0.94 | 0.53–1.64 | |
|
| 2.38 | 1.31–4.31 | |
|
|
| 1 [Reference] | |
|
| 0.83 | 0.49–1.42 | |
|
| 0.89 | 0.56–1.41 | |
|
| 1.36 | 0.87–2.13 | |